Unither Pharmaceuticals Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Private

  • Employees
  • 2,300

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 8

  • Investments
  • 10

Unither Pharmaceuticals General Information

Description

Provider of pharmaceutical-based contract manufacturing services intended for the healthcare and generic drug industry. The company specializes in the manufacture and packaging of sterile unit doses, non-sterile liquids, and solid and semi-solid medications with the help of blow-fill-seal (BFS) and liquid stick-packs technologies, as well as providing regulatory expertise, galenic development, and analytical services, thereby helping its clients to increasingly outsource the manufacture of their products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Espace Industriel Nord
  • 151 Rue André Durouchez CS 28028
  • 80084 Amiens
  • France
+33 01
Primary Industry
BPO/Outsource Services
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • Espace Industriel Nord
  • 151 Rue André Durouchez CS 28028
  • 80084 Amiens
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Unither Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Unither Pharmaceuticals‘s full profile, request access.

Request a free trial

Unither Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of pharmaceutical-based contract manufacturing services intended for the healthcare and generic drug industry.
BPO/Outsource Services
Amiens, France
2,300 As of 2026

Wilmington, NC
 

Burnaby, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Unither Pharmaceuticals Competitors (16)

One of Unither Pharmaceuticals’s 16 competitors is Alcami, a Private Equity-Backed company based in Wilmington, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alcami Private Equity-Backed Wilmington, NC
Pnp Pharmaceuticals Private Equity-Backed Burnaby, Canada
Recipharm Private Equity-Backed Stockholm, Sweden
Bend Bioscience (Formerly CoreRx) Private Equity-Backed Clearwater, FL
PCI Pharma Services Private Equity-Backed Philadelphia, PA
You’re viewing 5 of 16 competitors. Get the full list »

Unither Pharmaceuticals Patents

Unither Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4623919-A1 Composition comprising iota-carrageenan for the treatment of dry eyes, non-viral conjunctivitis and allergic ocular conditions Pending 28-Mar-2024
AU-2025246042-A1 Composition comprising iota-carrageenan for use in the treatment of dry eyes, non-viral and non-allergic eye conditions Pending 28-Mar-2024
FR-3154024-A1 Nasal spray and nasal spray method Pending 16-Oct-2023
EP-4541396-A1 Nasal sprayer and method for loading the nasal sprayer Active 16-Oct-2023
EP-4541396-B1 Nasal sprayer and method for loading the nasal sprayer Active 16-Oct-2023 A61M15/08
To view Unither Pharmaceuticals’s complete patent history, request access »

Unither Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Unither Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Unither Pharmaceuticals‘s full profile, request access.

Request a free trial

Unither Pharmaceuticals Investments (10)

Unither Pharmaceuticals’s most recent deal was a Buyout/LBO with Carragelose for . The deal was made on 28-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Carragelose 28-Feb-2025 Buyout/LBO Drug Discovery
BIOPHTA 01-Jun-2024 Seed Round Drug Delivery
Novartis (Plant in São Paulo) 28-Nov-2022 Buyout/LBO Buildings and Property
Curecall 13-Jul-2022 Early Stage VC Medical Records Systems
Curecall 21-Oct-2020 Seed Round Medical Records Systems
You’re viewing 5 of 10 investments. Get the full list »

Unither Pharmaceuticals Exits (3)

Unither Pharmaceuticals’s most recent exit was on 13-Jul-2022 from Curecall. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Curecall 13-Jul-2022 Completed
Curecall 21-Oct-2020 Completed
Créapharm Group 24-Nov-2005 Buyout/LBO Completed
  • 3 buyers
To view Unither Pharmaceuticals’s complete exits history, request access »

Unither Pharmaceuticals Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Unither Liquid Manufacturing Colomiers, France 2008
Unither Industries Gannat, France 2008
Carragelose Korneuburg, Austria 2007
Unither Developpement Bordeaux Le Haillan, France 2006

Unither Pharmaceuticals FAQs

  • When was Unither Pharmaceuticals founded?

    Unither Pharmaceuticals was founded in 1993.

  • Where is Unither Pharmaceuticals headquartered?

    Unither Pharmaceuticals is headquartered in Amiens, France.

  • What is the size of Unither Pharmaceuticals?

    Unither Pharmaceuticals has 2,300 total employees.

  • What industry is Unither Pharmaceuticals in?

    Unither Pharmaceuticals’s primary industry is BPO/Outsource Services.

  • Is Unither Pharmaceuticals a private or public company?

    Unither Pharmaceuticals is a Private company.

  • What is Unither Pharmaceuticals’s current revenue?

    The current revenue for Unither Pharmaceuticals is .

  • How much funding has Unither Pharmaceuticals raised over time?

    Unither Pharmaceuticals has raised $381M.

  • Who are Unither Pharmaceuticals’s investors?

    GIC Private, IK Partners, NiXEN Partners, Keensight Capital, and Parquest Capital are 5 of 6 investors who have invested in Unither Pharmaceuticals.

  • Who are Unither Pharmaceuticals’s competitors?

    Alcami, Pnp Pharmaceuticals, Recipharm, Bend Bioscience (Formerly CoreRx), and PCI Pharma Services are some of the 16 competitors of Unither Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process